Biodistribution and radiation dosimetry of [64Cu]copper dichloride: first-in-human study in healthy volunteers
Abstract Background In recent years, Copper-64 (T1/2 = 12.7 h) in the chemical form of copper dichloride ([64Cu]CuCl2) has been identified as a potential agent for PET imaging and radionuclide therapy targeting the human copper transporter 1, which is overexpressed in a variety of cancer cells. Limi...
Main Authors: | M.A. Avila-Rodriguez, C. Rios, J. Carrasco-Hernandez, J. C. Manrique-Arias, R. Martinez-Hernandez, F. O. García-Pérez, A. R. Jalilian, E. Martinez-Rodriguez, M. E. Romero-Piña, A. Diaz-Ruiz |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-12-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-017-0346-4 |
Similar Items
-
Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CT
by: Kristoffer Kjærgaard, et al.
Published: (2020-06-01) -
Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implications
by: Sergio Righi, et al.
Published: (2018-03-01) -
Pilot Study of 64CuCl2 for PET Imaging of Inflammation
by: Lei Jiang, et al.
Published: (2018-02-01) -
Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent
by: Gabriela Capriotti, et al.
Published: (2022-12-01) -
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
by: Giada Catalogna, et al.
Published: (2017-08-01)